Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Divis Laboratories to invest Rs 500 crore for setting up manufacturing facility in Andhra Pradesh, India
Monday, February 02, 2015Divis Laboratories Ltd a manufacturer of active pharmaceutical ingredients APIs intermediates is planning to invest Rs crore to set its third manufacturing facility in the country The company is considering setting up a third manufacturing site to...
Boston’s biotechnology startup Flex Pharma raises $86.4 million in IPO
Monday, February 02, 2015Shares of biotechnology startup Flex Pharma Inc lost percent in their first day of trading Thursday after the company raised million in an initial public offering The performance on a day of strong gains in the broader financial markets marked an...
Serendex Pharmaceuticals and CMC Biologics Enter Exclusive Agreement on Factor VIIa
Saturday, January 31, 2015Serendex Pharmaceuticals AS and CMC Biologics Inc have today signed an exclusive agreement on Factor VIIa Through the agreement Serendex Pharmaceuticals has secured access to a unique form of Factor VIIa and the agreement provides Serendex Pharmaceut...
Sun Pharmaceutical wins U.S. approval to buy Ranbaxy
Saturday, January 31, 2015Indias Sun Pharmaceutical Industries Ltd has won US approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine the US Federal Trade Commission said on Friday Sun Pharmaceutical said in April t...
Sanofi to set up insulin facility in Telangana, India
Friday, January 30, 2015French vaccine manufacturer Sanofi though its Indian entity Shantha Biotechnics will set up an insulin production facility in Telangana involving an investment of Rs crore Sanofi proposes to manufacture Insuman one of its leading human insulin prod...
Venaxis receives FDA “Not Substantially Equivalent” Response on APPY1 510(k) Submission
Friday, January 30, 2015Venaxis Inc an in vitro diagnostic company focused on advancing commercialization of its CE Marked APPY Test a rapid blood test for aiding in identifying children adolescent and young adult patients in the emergency room who are at low risk for appen...
Amerita, a Subsidiary of PharMerica, Accelerates Growth with the Acquisition of InfusionRx
Thursday, January 29, 2015Amerita Inc a wholly owned subsidiary of PharMerica Corporation NYSEPMC today announced that it has completed the acquisition of Coastal Pharmaceutical Services Corporation dba InfusionRx InfusionRx Financial terms of the transaction were not disclos...
Adamis Pharmaceuticals receives Notice of Allowance for US and Japanese Patents for its Dry Powder Inhaler
Thursday, January 29, 2015Adamis Pharmaceuticals Corporation recently received a notice of allowance that one of its patent applications for its proprietary dry powder inhaler Taper DPI will issue in the United States US Patent Application No and in Japan Japanese Patent App...
Ranbaxy forfeits 180 days exclusivity for generic Nexium
Wednesday, January 28, 2015Ranbaxy Laboratories has lost the opportunity to exclusively market in the United States for six months the first generic version of Anglo Swedish drug innovator Astra Zenecas heartburn drug Nexium the Delhibased company said in a filing to the stock...
IntelliCell BioSciences Licenses Indication for Diabetes to Invigorcell
Wednesday, January 28, 2015IntelliCell BioSciences Inc a regenerative medicine company utilizing adult autologous stromal vascular cells SVCs derived from the blood vessels found in adipose tissue today announced a license agreement for the indication of Diabetes Mellitus Inv...
